Precision Medicine

Momentum for more forward-looking SDOH initiatives is building across healthcare, as stakeholders recognize the key role of socioeconomic factors, environment and community in better health and wellness. But unlocking ROI will take some work.

A chat with Dr Ian Chuang, Chief Medical Officer, Elsevier.

The precision medicine company will work with the U.S. Food and Drug Administration to see how secure patient data can be better put to work in the development of oncology treatments.

The alliance, which includes UPMC, University of Pittsburgh and Carnegie Mellon University, will work with Amazon to better harness data for diagnosis, treatment and prevention.

In collaboration with Premier, the company will work with LifeBridge Health, Riverside Health and St. Luke's University Health Network to develop new machine learning algorithms for personalized care.

Andrew Rebhan, consultant at The Advisory Board, discusses new advances in "digital frontiers" such as artificial intelligence, internet of things, 3D printing, augmented reality and more.

Delivered by UNSW's Entrepreneurship Unit, the 20-week programme will include five health startups providing products and services focused on chronic diseases.

SNUH serves more than 8,000 cancer patients per year across 16 cancer specialty centres, 10 multidisciplinary cancer treatment centres, and a cancer clinical trials centre.

Kate Birch, head of data and technology at Melbourne Genomic Health Alliance in Australia, discusses how rare conditions are being identified and successfully treated through pediatric gene testing.

Finding the best care for a patient can be a constantly moving target.